Cancer stem cell markers as potential targets for epithelial cancers

Indian Journal of Experimental Biology

Volumn 49, Issue 11, 2011, Pages 826-835

  Madka, Venkateshwar ^a   Rao, Chinthalapally V ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer stem cells; CD1 3; DCAMKL 1; LGR5; Mushahi 1; Tumor initiating cells

Indexed keywords

CD133 ANTIGEN; DCLK1 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; LGR5 PROTEIN, HUMAN; MSI1 PROTEIN, HUMAN; NERVE PROTEIN; PEPTIDE; PROTEIN SERINE THREONINE KINASE; RNA BINDING PROTEIN; SIGNAL PEPTIDE; TUMOR MARKER;

CANCER STEM CELL; EPITHELIUM CELL; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

ANTIGENS, CD; EPITHELIAL CELLS; GLYCOPROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PEPTIDES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, G-PROTEIN-COUPLED; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 80355126175     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. http://seer.cancer.gov/csr/1975_2007/results_single/sect_01_table.01.pdf
2. Siegel R, Ward E, Brawley O & Jemal A, Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths, CA Cancer J Clin, 61 (2011) 212.
3. Jankowska H, Hooper P & Jankowski JA, Aspirin chemoprevention of gastrointestinal cancer in the next decade. A review of the evidence, Pol Arch Med Wewn, 120 (2010) 407.
4. Shukla Y & Singh R, Resveratrol and cellular mechanisms of cancer prevention, Ann N Y Acad Sci, 1215 (2011) 1.
5. Half E & Arber N, Colon cancer: preventive agents and the present status of chemoprevention, Expert Opin Pharmacother, 10 (2009) 211.
6. Morgan TR, Chemoprevention of hepatocellular carcinoma in chronic hepatitis C, Recent Results Cancer Res, 188 (2011) 85.
7. Morrison SJ & Kimble J, Asymmetric and symmetric stem-cell divisions in development and cancer, Nature, 441 (2006) 1068.
8. Barker N, van Es J H, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters P J & Clevers H, Identification of stem cells in small intestine and colon by marker gene Lgr5, Nature, 449 (2007) 1003.
9. Al-Hajj M, Wicha M S, Benito-Hernandez A, Morrison S J & Clarke MF. Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci USA, 100 (2003) 3983.
10. Li C, Heidt D G, Dalerba P, Burant C F, Zhang L, Adsay V, Wicha M, Clarke M F & Simeone D M. Identification of pancreatic cancer stem cells. Cancer Res. 67 (2007) 1030.
11. Cocciadiferro L, Miceli V, Kang K S, Polito L M, Trosko J E & Carruba G. Profiling cancer stem cells in androgenresponsive and refractory human prostate tumor cell lines. Ann N Y Acad Sci, 1155 (2009) 257.
12. Hamburger A W & Salmon S E, Primary bioassay of human tumor stem cells, Science, 197 (1977) 461.
13. Schubert M, Herbert N, Taubert I, Ran D, Singh R, Eckstein V, Vitacolonna M, Ho A D & Zöller M, Differential survival of AML subpopulations in NOD/SCID mice. Exp Hematol. 39 (2011) 250.
14. Ricci-Vitiani L, Lombardi D G, Pilozzi E, Biffoni M, Todaro M, Peschle C & De Maria R, Identification and expansion of human colon-cancer-initiating cells, Nature, 445 (2007) 111.
15. Singh S K, Clarke I D, Terasaki M, Bonn V E, Hawkins C, Squire J & Dirks P B, Identification of a cancer stem cell in human brain tumors, Cancer Res, 63 (2003) 5821.
16. O'Brien C A, Pollett A, Gallinger S & Dick J E, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, 445 (2007) 106.
17. Barker N, Rachel A R, van Es J H, van de W M, Begthel H, van den B M, Danenberg E, Clarke A R, Sansom O J & Clevers H, Crypt stem cells as the cells-of-origin of intestinal cancer, Nature, 457 (2009) 608.
18. Clarke R B, Ovarian steroids and the human breast: Regulation of stem cells and cell proliferation, Maturitas, 54 (2006) 327.
19. Houman D H, Nakano I, Lazareff J A, Masterman-Smith M, Geschwind D H, Bronner-Fraser M & Kornblum H I, Cancerous stem cells can arise from pediatric brain tumors, PNAS, 100 (2003) 15178.
20. Fang D, Nguyen T K, Leishear K, Finko R, Kulp A N, Hotz S, Van Belle P A, Xu X, Elder D E & Herlyn M, A tumorigenic subpopulation with stem cell properties in melanomas, Cancer Res, 65 (2005) 9328.
21. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti M A & Daidone M G, Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties, Cancer Res, 65 (2005) 5506.
22. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C & De Maria R, Identification and expansion of the tumorigenic lung cancer stem cell population, Cell Death Differ, 15 (2008) 504.
23. Bapat S A, Mali A M, Koppikar C B & Kurrey N K, Stem and Progenitor-Like Cells Contribute to the Aggressive Behavior of Human Epithelial Ovarian Cancer, Cancer Res, 65 (2005) 3025.
24. Zhang S, Balch C, Chan M W, Lai H C, Matei D, Schilder J M, Yan P S, Huang T H & Nephew K P, Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors, Cancer Res, 68 (2008) 4311.
25. Vermeulen L, Todaro M, de Sousa Mello F, Sprick M R, Kemper K, Perez Alea M, Richel D J, Stassi G & Medema J P, Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity, PNAS, 105 (2008) 13427.
26. Magni M, Shammah S, Schiró R, Mellado W, Dalla-Favera R & Gianni A M, Induction of Cyclophosphamide-Resistance by Aldehyde Dehydrogenase Gene Transfer, Blood, 87 (1996) 1097.
27. Sophos N A & Vasiliou V, Aldehyde dehydrogenase gene superfamily: the 2002 update, Chemico-Biol Interactions, 143-144 (2003) 5.
28. Yoshida A, Rzhetsky A, Hsu L C & Chang C, Human aldehyde dehydrogenase gene family, Eur J Biochem, 251 (1998) 549.
29. Dylla S J, Beviglia L, Park I K, Chartier C, Raval J, Ngan L, Pickell K, Aguilar J, Lazetic S, Smith-Berdan S, Clarke M F, Hoey T, Lewicki J & Gurney A L, Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy, PLoS One, 3 (2008) 2428.
30. Armstrong L, Stojkovic M, Dimmick I, Ahmad S, Stojkovic P, Hole N & Lako M, Phenotypic Characterization of Murine Primitive Hematopoietic Progenitor Cells Isolated on Basis of Aldehyde Dehydrogenase Activity, Stem cells, 22 (2004) 1142.
31. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, Strazzer S, Bresolin N & Comi G P, Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity, Stem Cells, 24 (2006) 975.
32. Huang E H, Hynes M J, Zhang T, Ginestier C, Dontu G, Appelman H, Fields J Z, Wicha M S & Boman B M, Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis, Cancer Res, 69 (2009) 3382.
33. Ginestier C, Hur M H, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer C G, Liu S, Schott A, Hayes D, Birnbaum D, Wicha M S & Dontu G, ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome, Cell Stem Cell, 1 (2007) 555.
34. Hess D A, Wirthlin L, Craft T P, Herrbrich P E, Hohm S A, Lahey R, Eades W C, Creer M H & Nolta J A, Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells, Blood, 107 (2006) 2162.
35. Ma S, Chan K W, Lee T K, Tang K H, Wo J Y, Zheng B J & Guan X Y, Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations, Mol Cancer Res, 6 (2008) 1146.
36. Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu Z, Stass S A & Jiang F, Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer, Cancer Epidemiol Biomarkers Prev, 19 (2010) 327.
37. Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, Stass S A & Jiang F, ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome, Lab Invest, 90 (2010) 234.
38. Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q, Li C, Wang L P, Roby K F, Orsulic S, Connolly D C, Zhang Y, Montone K, Bützow R, Coukos G & Zhang L, Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers, PloS ONE, 5 (2010) e10277.
39. Yin A H, Miraglia S, Zanjani E D, Almeida-Porada G, Ogawa M, Leary A G, Olweus J, Kearney J & Buck D W, AC133, a novel marker for human hematopoietic stem and progenitor cells, Blood, 90 (1997) 5002.
40. Miraglia S, Godfrey W, Yin A H, Atkins K, Warnke R, Holden J T, Bray R A, Waller E K & Buck D W, A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning, Blood, 90 (1997) 5013.
41. Uchida N, Buck D W, He D, Reitsma M J, Masek M, Phan T V, Tsukamoto A S, Gage F H & Weissman I L, Direct isolation of human central nervous system stem cells, PNAS, 97 (2000) 14720.
42. Richardson G D, Robson C N, Lang S H, Neal D E, Maitland N J & Collins A T, CD133, a novel marker for human prostatic epithelial stem cells, J Cell Sci, 117 (2004) 3539.
43. Sagrinati C, Netti G S, Mazzinghi B, Lazzeri E, Liotta F, Frosali F, Ronconi E, Meini C, Gacci M, Squecco R, Carini M, Gesualdo L, Francini F, Maggi E, Annunziato F, Lasagni L, Serio M, Romagnani S & Romagnani P, Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys, J Am Soc Nephrol, 17 (2006) 2443.
44. Kordes C, Sawitza I, Müller-Marbach A, Ale-Agha N, Keitel V, Klonowski-Stumpe H & Häussinger D, CD133+ hepatic stellate cells are progenitor cells, Biochem Biophys Res Commun, 352 (2007) 410.
45. Sugiyama T, Rodriguez R T, McLean G W & Kim S K, Conserved markers of fetal pancreatic epithelium permit prospective isolation of islet progenitor cells by FACS, PNAS, 104 (2007) 175.
46. Ito Y, Hamazaki T S, Ohnuma K, Tamaki K, Asashima M & Okochi H, Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133, J Invest Dermatol, 127 (2007) 1052.
47. Snippert H J, van Es J H, van den Born M, Begthel H, Stange D E, Barker N & Clevers H, Prominin-1/CD133 Marks Stem Cells and Early Progenitors in Mouse Small Intestine, Gastroenterol, 136 (2009) 2187.
48. Taylor M D, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T & Gilbertson R J, Radial glia cells are candidate stem cells of ependymoma, Cancer Cell, 8 (2005) 323.
49. Collins A T, Berry P A, Hyde C, Stower M J & Maitland N J, Prospective identification of tumorigenic prostate cancer stem cells, Cancer Res, 65 (2005) 10946.
50. Todaro M, Alea M P, Di Stefano A B, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema J P & Stassi G, Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4, Cell Stem Cell, 1 (2007) 389.
51. Ma S, Chan K W, Hu L, Lee T K, Wo J Y, Ng I O, Zheng B J & Guan X Y, Identification and characterization of tumorigenic liver cancer stem/progenitor cells, Gastroenterol, 132 (2007) 2542.
52. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C, Gritti A, Piccinini A, Porro D, Santinami M, Invernici G, Parati E, Alessandri G & La Porta C A, Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential, Eur J Cancer, 43 (2007) 935.
53. Hermann P C, Huber S L, Herrler T, Aicher A, Ellwart J W, Guba M, Bruns C J & Heeschen C, Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer, Cell Stem Cell, 1 (2007) 313.
54. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C & De Maria R, Identification and expansion of the tumorigenic lung cancer stem cell population, Cell Death Differ, 15 (2008) 504.
55. Curley M D, Therrien V A, Cummings C L, Sergent P A, Koulouris C R, Friel A M, Roberts D J, Seiden M V, Scadden D T, Rueda B R & Foster R, CD133 expression defines a tumor initiating cell population in primary human ovarian cancer, Stem Cells, 27 (2009) 2875.
56. Yang Z L, Zheng Q, Yan J, Pan Y & Wang Z G. Upregulated CD133 expression in tumorigenesis of colon cancer cells, World J Gastroenterol, 17 (2011) 932.
57. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner P J, Aigner L, Brawanski A, Bogdahn U, Beier C P, CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles, Cancer Res. 67 (2007) 4010.
58. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir I R, Lu L, Irvin D, Black K L & Yu J S, Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma, Mol Cancer, 5 (2006) 67.
59. Nakamura M, Okano H, Blendy J A & Montell C, Musashi, a neural RNA-binding protein required for Drosophila adult external sensory organ development, Neuron, 13 (1994) 67.
60. Sakakibara S, Imai T, Hamaguchi K, Okabe M, Aruga J, Nakajima K, Yasutomi D, Nagata T, KuriharaY, Uesugi S, Miyata T, Ogawa M, Mikoshiba K & Okano H, Mouse Musashi-1, a neural RNA binding protein highly enriched in the mammalian CNS stem cell, Dev Biol, 176 (1996) 230.
61. Potten C S, Booth C, Tudor G L, Booth D, Brady G, Hurley P, Ashton G, Clarke R, Sakakibara S & Okano H, Identification of a putative intestinal stem cell and early lineage marker: musashi-1, Differentiation, 7 (2003) 128.
62. Clarke R B, Isolation and characterization of human mammary stem cells, Cell Prolif, 38 (2005) 375.
63. Sakakibara S & Okano H, Expression of Neural RNABinding Proteins in the Postnatal CNS: Implications of Their Roles in Neuronal and Glial Cell Development, J Neurosci, 17 (1997) 8300.
64. Kaneko Y, Sakakibara S, Imai T, Suzuki A, Nakamura Y, Sawamoto K, Ogawa Y, Toyama Y, Miyata T & Okano H, Musashi1: An evolutionally conserved marker for CNS progenitor cells including neural stem cells, Dev Neurosci, 22 (2000) 139.
65. Okano H, Imai T & Okabe M, Musashi: a translational regulator of cell fate, J Cell Sci, 115 (2002) 1355.
66. Booth C & Potten C S, Gut instincts: thoughts on intestinal epithelial stem cells, J Clin Invest, 105 (2000) 1493.
67. Kayahara T, Sawada M, Takashi S, Fukui H, Seno H, Fukuzawa H, Suzuki K, Hiai H, Kageyama R, Okano H & Chiba T, Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine, FEBS Lett, 535 (2003) 131.
68. Okano H, Kawahara H, Toriya M, Nakao K, Shibata S & Imai T, Function of RNA binding protein Musashi-1 in stem cells, Exp Cell Res, 306 (2005) 349.
69. Yokota N, Mainprize T G, Taylor M D, Kohata T, Loreto M, Ueda S, Dura W, Grajkowska W, Kuo J S & Rutka J T. Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization, Oncogenes, 23 (2004) 3444.
70. Toda M, Iizuka Y, Yu W, Imai T, Ikeda E, Yoshida K, Kawase T, Kawakami Y, Okano H & Uyemura K, Expression of the neural RNA-binding protein Musashi1 in human gliomas, Glia, 34 (2001) 1.
71. Ma Y H, Mentlein R, Knerlich F, Kruse M L, Mehdorn H M & Held-Feindt J, Expression of stem cell markers in human astrocytomas of different WHO grades, J Neurooncol, 86 (2008) 31.
72. Seigel G M, Hackam A S, Ganguly A, Mandell L M & Gonzalez-Fernandez F, Human embryonic and neuronal stem cell markers in retinoblastoma, Mol Vis, 13 (2007) 823.
73. Götte M, Wolf M, Staebler A, Buchweitz O, Kelsch R, Schüring A & Kiesel L, Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma, J Pathol, 215 (2008) 317.
74. Shu H J, Saito T, Watanabe H, Ito J I, Takeda H, Okano H & Kawata S, Expression of the Musashi1 gene encoding the RNA-binding protein in human hepatoma cell lines, Biochem Biophys Res Commun, 293 (2002) 150.
75. Ye F, Zhou C, Cheng Q, Shen J & Chen H, Stem-cellabundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells, BMC Cancer, 8 (2008) 108.
76. Fan L F, Dong W G, Jiang C Q, Xia D, Liao F & Yu Q F, Expression of putative stem cell genes Musashi-1and _1-integrin in human colorectal adenomas and adenocarcinomas, Int J Colorectal Dis, 25 (2010) 17.
77. Wang X Y, Penalva L O, Yuan H, Linnoila R I, Lu J, Okano H & Glazer R I, Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival, Mol Cancer, 9 (2010) 221.
78. Dobson N R, Zhou Y X, Flint N C & Armstrong R C, Musashi1 RNA-binding protein regulates oligodendrocyte lineage cell differentiation and survival, Glia, 56 (2008) 318.
79. Wang X Y, Yin Y, Yuan H, Sakamaki T, Okano H & Glazer R I, Musashi1modulates mammary progenitor cell expansion through proliferinmediated activation of the Wnt and Notch pathways, Mol Cell Biol, 28 (2008) 3589.
80. Sureban S M, May R, George R J, Dieckgraefe B K, McLeod H L, Ramalingam S, Bishnupuri K S, Natarajan G, Anant S & Houchen C W, Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo, Gastroenterol, 134 (2008) 1448.
81. Sanchez-Diaz P C, Burton T L, Burns S C, Hung J Y & Penalva LO, Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy, BMC Cancer, 8 (2008) 280.
82. Hsu S Y, New insights into the evolution of the relaxin-LGR signaling system, Trends Endocrinol Metab, 14 (2003) 303.
83. Hsu S Y, Kudo M, Chen T, Nakabayashi K, Bhalla A, van der Spek P J, van Duin M & Hsueh A J, The three subfamilies of leucine-rich repeatcontaining G proteincoupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7, Mol Endocrinol, 14 (2000) 1257.
84. Morita H, Mazerbourg S, Bouley D M, Luo C W, Kawamura K, Kuwabara Y, Baribault H, Tian H & Hsueh A J, Neonatal lethality of LGR5 null mice is associated with ankyloglossia and gastrointestinal distension, Mol Cell Biol, 24 (2000) 9736.
85. Garcia M I, Ghiani M, Lefort A, Libert F, Strollo S & Vassart G, LGR5 deficiency deregulates Wnt signaling and leads to precocious Paneth cell differentiation in the fetal intestine, Develop Biol, 331 (2009) 58.
86. Barker N, van Es J H, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters P J & Clevers H, Identification of stem cells in small intestine and colon by marker gene Lgr5, Nature. 449 (2007) 1003.
87. Yamamoto Y, Sakamoto M, Fujii G, Tsuiji H, Kenetaka K, Asaka M & Hirohashi S, Overexpression of orphan G-proteincoupled receptor. Gpr49, in human hepatocellular carcinomas with catenin mutations, Hepatology, 37 (2003) 528.
88. McClanahan T, Koseoglu S, Smith K, Grein J, Gustafson E, Black S, Kirschmeier P & Samatar A A, Identification of Orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors, Cancer Biol Ther, 5 (2006) 419.
89. Uchida H, Yamazaki K, Fukuma M, Yamada T, Hayashida T, Hasegawa H, Kitajima M, Kitagawa Y & Sakamoto M, Overexpression of leucine-rich repeat-containing G proteincoupled receptor 5 in colorectal cancer, Cancer Sci, 101 (2010) 1731.
90. Li S, Huang S & Peng S B, Overexpression of G proteincoupled receptors in cancer cells: Involvement in tumor progression, Int J Oncology, 27 (2005) 1329.
91. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H & Berns A, Identification of cooperating oncogenes in Em-myc transgenic mice by provirus tagging, Cell, 65 (1991) 737.
92. Valk-Lingbeek M E, Bruggeman S W & van Lohuizen M, Stem cells and cancer: the Polycomb connection, Cell, 118 (2004) 409.
93. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger D J, Campan M, Young J, Jacobs I & Laird P W. Epigenetic stem cell signature in cancer, Nat Genet, 39 (2007) 157.
94. van der Lugt N M, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H, van der Valk M, Deschamps J, Sofroniew M & van Lohuizen M, Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto oncogene, Genes Dev, 8 (1994) 757.
95. Park I K, Qian D, Kiel M, Becker M W, Pihalja M, Weissman I L, Morrison S J & Clarke M F, Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells, Nature, 423 (2003) 302.
96. Sangiorgi E & Capecchi M R, Bmi1 is expressed in vivo in intestinal stem cells, Nat Genet, 40 (2008) 915.
97. Sangiorgi E & Capecchi M R, Bmi1 lineage tracing identifies a self-renewing pancreatic acinar cell subpopulation capable of maintaining pancreatic organ homeostasis, PNAS, 106 (2009) 7101.
98. Liu L, Andrews LG & Tollefsbol T O, Loss of the human polycomb group protein BMI1promotes cancer-specific cell death, Oncogene, 25 (2006) 4370.
99. Silva J, García V, García J M, Peña C, Domínguez G, Díaz R, Lorenzo Y, Hurtado A, Sánchez A & Bonilla F, Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients, Breast Cancer Res, 9 (2007) R55100
100. Beà S, Tort F, Pinyol M, Puig X, Hernández L, Hernández S, Fernandez P L, van Lohuizen M, Colomer D & Campo E, BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas, Cancer Res, 61 (2001) 2409.
101. Dukers D, van Galen J C, Giroth C, Jansen P, Sewalt R G, Otte A P, Kluin-Nelemans H C, Meijer C J & Raaphorst F M, Unique Polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines, Am J Pathol, 164 (2004) 873.
102. Vonlanthen S, Heighway J, Altermatt H J, Gugger M, Kappeler A, Borner M M, van Lohuizen M & Betticher D C, The bmi-1 oncoprotein is differentially expressed in nonsmall cell lung cancer and correlates with INK4A-ARF locus expression, Br J Cancer, 84 (2001) 1372.
103. Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani, Van Lohuizen M & Marino S, Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas, Nature, 428 (2004) 337.
104. Nowak K, Kerl K, Fehr D, Kramps C, Gessner C, Killmer K, Samans B, Berwanger B, Christiansen H & Lutz W, BMI-1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas, Nucleic Acids Res, 34 (2006) 1745.
105. Neo S Y, Leow C K, Vega V B, Long P M, Islam A F, Lai P B, Liu E T & Ren E C, Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach, Hepathology, 39 (2004) 944.
106. Kim J H, Yoon S Y, Jeong S H, Kim S Y, Moon S K, Joo J H, Lee Y, Choe I S & Kim J W, Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer, Breast, 13 (2004) 383.
107. Kim J H, Yoon S Y, Kim C N, Joo J H, Moon S K, Choe I S, Choe Y K & Kim J W, The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/ p14ARF proteins, Cancer Lett, 203 (2004) 217.
108. Song L B, Zeng M S, Liao W T, Zhang L, Mo H Y, Liu W L, Shao J Y, Wu Q L, Li M Z, Xia Y F, Fu L W, Huang W L, Dimri G P, Band V & Zeng Y X, Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells, Cancer Res, 66 (2006) 6225.
109. Berezovska O P, Glinskii A B, Yang Z, Li X M, Hoffman R M & Glinsky G V, Essential role for activation of the Polycomb group [PcG] protein chromatin silencing pathway in metastatic prostate cancer, Cell Cycle, 5 (2006) 1886.
110. Qin Z K, Yang J A, Ye Y L, Zhang X, Xu L H, Zhou F J, Han H, Liu Z W, Song L B & Zeng M S, Expression of Bmi-1 is a prognostic marker in bladder cancer, BMC Cancer, 9 (2009) 61.
111. Lin P T, Gleeson J G, Corbo J C, Flanagan L & Walsh C A, DCAMKL1 Encodes a Protein Kinase with Homology to Doublecortin that Regulates Microtubule Polymerization, The J Neurosci, 20 (2000) 9152.
112. Giannakis M, Stappenbeck T S, Mills J C, Leip D G, Lovett M, Clifton S W, Ippolito J E, Glasscock J I, Arumugam M, Brent M R & Gordon J I, Molecular Properties of Adult Mouse Gastric and Intestinal Epithelial Progenitors in Their Niches, J Biol Chem, 281 (2006) 11292.
113. May R, Riehl T E, Hunt C, Sureban S M, Anant S, & Houchen C W, Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice, Stem Cells, 26 (2008) 630.
114. May R J, Sureban S M, Lightfoot S A, Hoskins A B, Brackett D J, Postier R G, Ramanujam R, Rao C V, Wyche J H, Anant S & Houchen C W, Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas, Am J Physiol Gastrointest Liver Physiol, 299 (2010) G303.
115. Sossey-Alaoui K & Srivastava A K, DCAMKL1, a Brain-Specific Transmembrane Protein on 13q12.3That Is Similar to Doublecortin (DCX), Genomics, 56 (1999) 121.
116. Sureban S M, May R, Ramalingam S, Subramaniam D, Natarajan G, Anant S & Houchen C W, Selective Blockade of DCAMKL-1 Results in Tumor Growth Arrest by a Let-7a MicroRNA-Dependent Mechanism, Gastroenterol, 137 (2009) 649.
117. Gerbe F, Brulin B, Makrini L, Legraverend C & Jay P, DCAMKL-1 Expression Identifies Tuft Cells Rather Than Stem Cells in the Adult Mouse Intestinal Epithelium, Gastroenterol, 137 (2009) 2179.
118. Dean M, Fojo T & Bates S, Tumour stem cells and drug resistance, Nat Rev Cancer, 5 (2005) 275.
119. Diehn M, Cho R W, Lobo N A, Kalisky T, Dorie M J, Kulp A N, Qian D, Lam J S, Ailles L E, Wong M, Joshua B, Kaplan M J, Wapnir I, Dirbas F M, Somlo G, Garberoglio C, Paz B, Shen J, Lau S K, Quake S R, Brown J M, Weissman I L & Clarke M F, Association of reactive oxygen species levels and radioresistance in cancer stem cells, Nature, 458 (2009) 780.
120. Fillmore C & Kuperwasser C, Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy, Breast Cancer Res, 10 (2008) R25.
121. Li X, Lewis M T, Huang J, Gutierrez C, Osborne C K, Wu M F, Hilsenbeck S G, Pavlick A, Zhang X, Chamness G C, Wong H, Rosen J & Chang J C. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy, J Natl Cancer Inst, 100 (2008) 672.
122. Ischenko I, Seeliger H, Schaffer M, Jauch K W & Bruns C J, Cancer stem cells: How can we target them?, Curr Med Chem, 15 (2008) 3171.
123. Yao J, Zhang T, Ren J, Yu M, Wu G, Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells, Oncol Rep 22 (2009) 781.
124. Chen Y C, Chang C J, Hsu H S, Chen Y W, Tai L K, Tseng L M, Chiou G Y, Chang S C, Kao S Y, Chiou S H, Lo W L, Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1, Oral Oncol, 46 (2010) 158.